“Sakura Finetek USA’s commitment to increasing our menu for IHC as well as ISH is vital to our mission of improving the clinical value and utility of Sakura Finetek branded products and advancing the quality of patient care.  Bringing CISH testing to our portfolio is critical to furthering the capabilities of our product line,” stated William Jennings, Senior Product Manager of Advanced Staining. These products are in vitro diagnostic devices (IVD) or analyte specific reagents (ASR).